SEC Form 4 · accession 0001179110-16-021298
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura J Schumacher
Officer — Executive Vice President
Period of report
Mar 8, 2016
Accepted (ET)
Mar 8, 2016 · 5:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par value | Mar 8, 2016 | S | 19,900 | $56.09 | D | 199,238 | D | |
| Common stock, $0.01 par value | Mar 8, 2016 | S | 3,400 | $56.10 | D | 195,838 | D | |
| Common stock, $0.01 par value | Mar 8, 2016 | S | 500 | $56.11 | D | 195,338 | D | |
| Common stock, $0.01 par value | Mar 8, 2016 | S | 300 | $56.12 | D | 195,038 | D | |
| Common stock, $0.01 par value | Mar 8, 2016 | S | 800 | $56.13 | D | 194,238 | D | |
| Common stock, $0.01 par value | Mar 8, 2016 | S | 100 | $56.15 | D | 194,138 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The sales were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).